文献速递泌尿男性生殖肿瘤

miR-527靶向Bcl-2抑制膀胱尿路上皮癌细胞迁移并促进凋亡

[MiR-527 targeting Bcl-2 inhibits migration and promotes apoptosis in bladder urothelial cell carcinoma].
PubMed 文献 · Zhonghua Zhong Liu Za Zhi · 2026-01-01

该研究探讨miR-527在膀胱尿路上皮癌中的表达及其通过靶向Bcl-2调控细胞迁移与凋亡的机制。数据库分析显示膀胱癌组织中miR-527表达显著高于正常组织,Bcl-2蛋白显著降低;双荧光素酶实验证实miR-527直接靶向Bcl-2。抑制miR-527上调Bcl-2并增强迁移、减少凋亡,过表达则相反;动物实验中过表达miR-527抑制肿瘤生长并降低Bcl-2和Ki-67表达。

要点

  • 膀胱癌组织中miR-527表达显著高于正常膀胱组织,Bcl-2蛋白显著降低。
  • 双荧光素酶实验证实miR-527直接靶向Bcl-2。
  • 过表达miR-527抑制膀胱癌细胞迁移、诱导凋亡并抑制裸鼠移植瘤生长。

核心结论

  • miR-527在膀胱癌组织中高表达,过表达miR-527通过负调控Bcl-2抑制膀胱癌细胞生长和迁移并诱导凋亡。

研究设计与样本

  • 利用癌症基因组图谱数据库分析miR-527在膀胱尿路上皮癌组织中的表达。
  • 通过实时荧光定量逆转录聚合酶链反应验证膀胱尿路上皮癌细胞系中miR-527的表达。
  • 采用双荧光素酶报告基因验证miR-527与靶基因Bcl-2的关系。
  • 构建miR-527 inhibitor和miR-527 mimic进行细胞转染,用细胞划痕实验及流式细胞术检测细胞迁移和凋亡,Western blot检测相关蛋白表达。
  • 采用裸鼠细胞源性异种移植和免疫组化验证体内成瘤和Bcl-2、Ki-67表达情况。

主要发现

  • 膀胱癌组织中miR-527表达显著高于正常膀胱组织,Bcl-2蛋白表达显著降低。
  • 抑制miR-527后Bcl-2 mRNA及蛋白表达水平显著升高(均P<0.01),细胞迁移能力增强、凋亡细胞减少。
  • T24细胞miR-527抑制组与对照组迁移率分别为(100.00±0.00)%与(47.74±2.18)%,凋亡率分别为(2.68±1.28)%与(11.82±5.19)%,均P<0.05。
  • UMUC-3细胞miR-527过表达组与对照组迁移率分别为(45.22±3.66)%与(100.00±0.00)%,凋亡率分别为(11.74±0.64)%与(3.81±0.75)%,均P<0.05。
  • 动物实验中过表达miR-527显著抑制肿瘤生长并减弱Bcl-2及Ki-67表达,抑制miR-527则促进肿瘤生长、增加肿瘤细胞异型性并增强Bcl-2及Ki-67表达。

临床怎么用

  • miR-527/Bcl-2轴可作为膀胱尿路上皮癌基础研究中的候选调控通路,但尚需临床样本与在体研究验证其转化价值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the expression of miR-527 in bladder urothelial cell carcinoma tissues (UCC) and cell lines, and to explore the mechanism by which miR-527 inhibits bladder cancer cell migration and promotes apoptosis through targeting Bcl-2. Methods: The expression of miR-527 in bladder UCC was analyzed using The Cancer Genome Atlas database. The expression of miR-527 in bladder UCC cell lines was verified by real-time quantitative reverse transcription polymerase chain reaction. The relationship between miR-527 and its target gene Bcl-2 was validated using a dual-luciferase reporter assay. miR-527 inhibitor and miR-527 mimic were constructed for cell transfection. Cell migration and apoptosis were assessed using wound healing assay and flow cytometry. Protein expression was detected by Western blot. In vivo tumorigenesis and the expressions of Bcl-2 and Ki-67 were evaluated using a nude mouse cell-derived xenograft model and immunohistochemistry. Results: Analysis of The Cancer Genome Atlas database revealed that miR-527 expression was significantly higher in bladder cancer tissues than in normal bladder tissues, whereas Bcl-2 protein expression was significantly lower. Dual-luciferase reporter assay confirmed that miR-527 directly targeted Bcl-2. Inhibition of miR-527 significantly upregulated Bcl-2 mRNA and protein levels (both P<0.01), enhanced cell migration, and reduced apoptosis [migration rate: (100.00±0.00)% in the miR-527 inhibitor group vs. (47.74 ± 2.18)% in the T24 control group; apoptosis rate: (2.68±1.28)% vs. (11.82±5.19)%; both P<0.05]. Overexpression of miR-527 produced opposite effects [migration rate: (45.22±3.66)% in the miR-527 overexpression group vs. (100.00±0.00)% in the UMUC-3 control group; apoptosis rate: (11.74±0.64)% vs. (3.81±0.75)%; both P<0.05]. In animal experiments, overexpression of miR-527 significantly inhibited tumor growth and reduced the expressions of Bcl-2 and Ki-67 in tumor tissues, whereas inhibition of miR-527 promoted tumor growth, increased tumor cellular atypia, and enhanced the expressions of Bcl-2 and Ki-67. Conclusions: miR-527, as a tumor-associated gene, is highly expressed in bladder cancer tissues. Overexpression of miR-527 inhibits the growth and migration of bladder cancer cells and induces apoptosis by negatively regulating the Bcl-2. 目的: 探讨miR-527在膀胱尿路上皮癌组织和细胞系中的表达及其通过靶向Bcl-2抑制膀胱癌细胞迁移并促进癌细胞凋亡的机制。 方法: 利用癌症基因组图谱数据库分析miR-527在膀胱尿路上皮癌组织中的表达,通过实时荧光定量逆转录聚合酶链反应验证膀胱尿路上皮癌细胞系中miR-527的表达,双荧光素酶报告基因验证miR-527与靶基因Bcl-2的关系,构建miR-527 inhibitor和miR-527 mimic进行细胞转染,细胞划痕实验及流式细胞术检测细胞迁移和凋亡情况,Western blot检测相关蛋白表达,裸鼠细胞源性异种移植和免疫组化验证体内成瘤和Bcl-2、Ki-67表达情况。 结果: 通过癌症基因组图谱数据库分析,膀胱癌组织中miR-527表达显著高于正常膀胱组织,Bcl-2蛋白表达显著降低。双荧光素酶报告基因实验证实miR-527可直接靶向Bcl-2。抑制miR-527表达后,Bcl-2 mRNA及蛋白表达水平显著升高(均P<0.01),细胞迁移能力增强,凋亡细胞减少[T24细胞miR-527抑制组、T24细胞对照组细胞迁移率:(100.00±0.00)%、(47.74±2.18)%,细胞凋亡率:(2.68±1.28)%、(11.82±5.19)%,均P<0.05],但过表达miR-527则相反[UMUC-3细胞miR-527过表达组和UMUC-3 细胞对照组细胞迁移率:(45.22±3.66)%、(100.00±0.00)%,细胞凋亡率:(11.74±0.64)%、(3.81±0.75)%,均P<0.05]。在动物实验中,过表达miR-527显著抑制肿瘤生长,肿瘤组织中Bcl-2及Ki-67表达减弱;抑制miR-527则促进肿瘤生长,肿瘤细胞异型性增加,Bcl-2及Ki-67表达增强。 结论: miR-527作为一种肿瘤相关基因,在膀胱癌组织中高表达,同时过表达miR-527可通过靶向负调控Bcl-2基因抑制膀胱癌肿瘤细胞生长和迁移,并诱导肿瘤细胞凋亡。.

来源:Zhonghua Zhong Liu Za Zhi,查看原文。版权归原作者所有。

引用

  1. Ma L, Zhang YY, Wang L, et al. [MiR-527 targeting Bcl-2 inhibits migration and promotes apoptosis in bladder urothelial cell carcinoma]. Zhonghua Zhong Liu Za Zhi. 2026. PMID: 42331549. doi:10.3760/cma.j.cn112152-20250813-00399

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。